Literature DB >> 17607043

Recruiting healthy volunteers for research participation via internet advertising.

Katrina A Bramstedt1.   

Abstract

OBJECTIVE: The Internet is frequently used as a tool to recruit research subjects, and the US Food and Drug Administration (FDA) provides general guidance regarding such advertising. The goal of this study was to explore the incidence and nature of ethically inappropriate recruiting advertisements on the Internet and to provide descriptive guidance to researchers for responsible Internet recruiting.
METHODS: In this study, 119 advertisements recruiting health volunteers and listed on the CenterWatch Clinical Trials Listing Service website were reviewed for content as well as text style and visual effects.
RESULTS: The majority of advertisements satisfied FDA guidance. However, 21 (18%) were ethically troubling with regard to font size, font style, and/or verbiage. In many advertisements, it was unclear if "medication" meant "investigational drug," "over-the-counter medication" or US FDA approved "prescription medication." Nearly 30% of the 119 advertisements used the terms "free," "no charge" or "no cost" as lures.
CONCLUSION: Ethically problematic recruiting advertisements can be coercive and misleading. Descriptive guidance provided in this paper can help clinical researchers create ethically appropriate recruiting advertisements.

Entities:  

Mesh:

Year:  2007        PMID: 17607043      PMCID: PMC1905931          DOI: 10.3121/cmr.2007.718

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  11 in total

1.  The hospital library online--a point of service for consumers and hospital staff: a case study.

Authors:  N J Cain; H J Fuller
Journal:  Bull Med Libr Assoc       Date:  1999-07

2.  Unique risks to volunteers in HIV vaccine trials.

Authors:  Sharon E Frey
Journal:  J Investig Med       Date:  2003-02       Impact factor: 2.895

3.  Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials?

Authors:  Carl L Tishler; Suzanne Bartholomae
Journal:  Perspect Biol Med       Date:  2003       Impact factor: 1.416

4.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

5.  Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials.

Authors:  J Bigorra; J E Baños
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Medical histories may be unreliable in screening volunteers for clinical trials.

Authors:  G Apseloff; J K Swayne; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1996-09       Impact factor: 6.875

7.  Motives and perception of healthy volunteers who participate in experiments.

Authors:  C E van Gelderen; T J Savelkoul; W van Dokkum; J Meulenbelt
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  The importance of measuring cotinine levels to identify smokers in clinical trials.

Authors:  G Apseloff; H M Ashton; H Friedman; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1994-10       Impact factor: 6.875

9.  Why do women volunteer to participate in clinical studies?

Authors:  A Pickersgill; H Furniss; M W Seif
Journal:  J Obstet Gynaecol       Date:  1998-01       Impact factor: 1.246

10.  Protecting the uninsured human research subject.

Authors:  D R Vasgird; M Hensleigh; A Berkman; E Schachne; C Trinh
Journal:  J Public Health Manag Pract       Date:  2000-11
View more
  3 in total

Review 1.  Healthy volunteers and early phases of clinical experimentation.

Authors:  Giuseppe Pasqualetti; Giovanni Gori; Corrado Blandizzi; Mario Del Tacca
Journal:  Eur J Clin Pharmacol       Date:  2010-05-12       Impact factor: 2.953

2.  CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.

Authors:  Thomas M Shiovitz; Charles S Wilcox; Lilit Gevorgyan; Adnan Shawkat
Journal:  Innov Clin Neurosci       Date:  2013-02

3.  Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic.

Authors:  Selena Russo; Marco Bani; Marco Terraneo; Valeria Quaglia; Giampaolo Nuvolati; Rebecca Cavaliere; Serena Capici; Marina Elena Cazzaniga; Maria Grazia Strepparava
Journal:  Eur J Clin Pharmacol       Date:  2022-09-14       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.